Abnormalities of p53 in chronic B-cell leukaemias.

被引：0
|
作者：
Lens, D
DeSchouwer, PJJC
Hamoudi, RA
Farahat, N
Matutes, E
Dyer, MJS
Catovsky, D
机构：
[1] ROYAL MARSDEN HOSP,ACAD DEPT HAEMATOL & CYTOGENET,SUTTON,SURREY,ENGLAND
[2] CANC RES INST,LONDON,ENGLAND
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1996年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：292 / 292
页数：1
相关论文
共 50 条
  • [31] Correlation of TP53 Aberrations with P53 Staining and Outcomes in Large B-Cell Lymphomas
    Bhavsar, Shweta
    Aggarwal, Nidhi
    Moore, Erika
    Yatsenko, Svetlana
    Swerdlow, Steven
    LABORATORY INVESTIGATION, 2019, 99
  • [32] B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia
    Marti, GE
    Carter, P
    Abbasi, F
    Washington, GC
    Jain, N
    Zenger, VE
    Ishibe, N
    Goldin, L
    Fontaine, L
    Weissman, N
    Sgambati, M
    Fauget, G
    Bertin, P
    Vogt, RF
    Slade, B
    Noguchi, PD
    Stetler-Stevenson, MA
    Caporaso, N
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2003, 52B (01) : 1 - 12
  • [33] Monitoring of the status of both p53 alleles in patients with B-cell chronic lymphocytic leukemia - Relevance to prognosis and treatment
    Malcikova, J.
    Trbusek, M.
    Smardova, J.
    Cejkova, S.
    Kuglik, P.
    Brychtova, Y.
    Doubek, M.
    Dvorakova, D.
    Mayer, J.
    Pospisilova, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 37 - 37
  • [34] P53 GENE DELETION PREDICTS FOR POOR SURVIVAL AND NONRESPONSE TO THERAPY WITH PURINE ANALOGS IN CHRONIC B-CELL LEUKEMIAS
    DOHNER, H
    FISCHER, K
    BENTZ, M
    HANSEN, K
    BENNER, A
    CABOT, G
    DIEHL, D
    SCHLENK, R
    COY, J
    STILGENBAUER, S
    VOLKMANN, M
    GALLE, PR
    POUSTKA, A
    HUNSTEIN, W
    LICHTER, P
    BLOOD, 1995, 85 (06) : 1580 - 1589
  • [35] A unique spectrum of p53 mutations in B-cell chronic lymphocytic leukemia distinct from that of other lymphoid malignancies
    Newcomb, EW
    ElRouby, S
    Thomas, A
    MOLECULAR CARCINOGENESIS, 1995, 14 (04) : 227 - 232
  • [36] P53 GENE DELETION PREDICTS FOR POOR SURVIVAL AND NONRESPONSE TO TREATMENT WITH PURINE ANALOGS IN CHRONIC B-CELL LEUKEMIAS
    DOHNER, H
    FISCHER, K
    STILGENBAUER, S
    BENTZ, M
    HANSEN, K
    WEISS, G
    BENNER, A
    SCHLENK, R
    COY, J
    VOLKMANN, M
    GALLE, PR
    HUNSTEIN, W
    LICHTER, P
    BLOOD, 1994, 84 (10) : A439 - A439
  • [37] NOVEL SMALL DELETIONS OF THE P53 GENE IN LATE-STAGE B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
    GANDINI, D
    AGUIARI, GL
    CUNEO, A
    PIVA, R
    CASTOLDI, GL
    DELSENNO, L
    BRITISH JOURNAL OF HAEMATOLOGY, 1994, 88 (04) : 881 - 885
  • [38] Changes in Bcl-2 and p53 expression in recurrent B-cell lymphomas
    Ilyas, M
    Kendall, M
    Jalal, H
    Linton, C
    Rooney, N
    JOURNAL OF PATHOLOGY, 1996, 180 (03): : 249 - 253
  • [39] Statins in mature B-cell lymphomas and leukaemias
    Smyth, Liam
    Blunt, Danielle N.
    Cheung, Matthew C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (04) : 490 - 492
  • [40] UV-induced B-cell lymphomas in p53 heterozygous mice.
    Miyahara, Y
    Kazimi, N
    Multani, AS
    Pathak, S
    Chang, S
    Angkasekwinai, Y
    Qin, XF
    Ullrich, SE
    BLOOD, 2004, 104 (11) : 385A - 385A
12345